60 phenotypes from 6 alleles in 7 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Slc18a2tm1.1Bgir/Slc18a2tm1.1Bgir Slc6a4tm1(cre)Xz/Slc6a4+ involves: 129S1/Sv * C57BL/6J	abnormal catecholamine level	J:197966
	abnormal emotion/affect behavior	J:197966
	decreased anxiety-related response	J:197966
	decreased locomotor activity	J:197966
	decreased serotonin level	J:197966
	normal nervous system phenotype	J:197966
	postnatal lethality, incomplete penetrance	J:197966
Slc18a2tm1Edw/Slc18a2+ involves: 129X1/SvJ * C57BL/6	abnormal noradrenaline level	J:45183
	abnormal serotonin level	J:45183
	decreased dopamine level	J:45183
Slc18a2tm1Edw/Slc18a2tm1Edw involves: 129X1/SvJ	abnormal dopaminergic neuron morphology	J:96932
	abnormal neurotransmitter secretion	J:96932
	abnormal synaptic vesicle morphology	J:96932
	decreased dopamine level	J:96932
Slc18a2tm1Edw/Slc18a2tm1Edw involves: 129X1/SvJ * C57BL/6	abnormal neurotransmitter secretion	J:45183
	abnormal noradrenaline level	J:45183
	abnormal serotonin level	J:45183
	absent gastric milk in neonates	J:45183
	bradykinesia	J:45183
	decreased body size	J:45183
	decreased body weight	J:45183
	decreased dopamine level	J:45183
	postnatal lethality, complete penetrance	J:45183
Slc18a2tm1Kmo/Slc18a2tm1Kmo involves: 129P2/OlaHsd * C57BL/6	neonatal lethality, complete penetrance	J:70606
Slc18a2tm1Mca/Slc18a2+ B6.129X1-Slc18a2tm1Mca	abnormal associative learning	J:125273
	abnormal corticosterone level	J:125273
	abnormal liquid preference	J:125273
	normal behavior/neurological phenotype	J:125273
	decreased coping response	J:125273
	decreased locomotor activity	J:125273
	decreased vertical activity	J:125273
	enhanced long-term potentiation	J:89778
Slc18a2tm1Mca/Slc18a2+ involves: 129X1/SvJ	abnormal neurotransmitter secretion	J:45184
	abnormal neurotransmitter uptake	J:45184
	decreased dopamine level	J:45184
	decreased physiological sensitivity to xenobiotic	J:45184
	enhanced behavioral response to addictive substance	J:45184
	impaired behavioral response to cocaine	J:45184
Slc18a2tm1Mca/Slc18a2+ involves: 129X1/SvJ * C57BL/6J	abnormal liquid preference	J:124481
	normal behavior/neurological phenotype	J:124481
	decreased alcohol consumption	J:124481
	impaired conditioned place preference behavior	J:124481
Slc18a2tm1Mca/Slc18a2tm1Mca involves: 129X1/SvJ	abnormal dopamine level	J:45184
	abnormal enzyme/coenzyme activity	J:45184
	abnormal synaptic neurotransmitter level	J:45184
	decreased birth body size	J:45184
	decreased body temperature	J:45184
	decreased locomotor activity	J:45184
	postnatal growth retardation	J:45184
	postnatal lethality, complete penetrance	J:45184
Slc18a2tm1Uhl/Slc18a2+ involves: 129S7/SvEvBrd * C57BL/6J	enhanced behavioral response to addictive substance	J:42811
	impaired conditioned place preference behavior	J:42811
	increased susceptibility to dopaminergic neuron neurotoxicity	J:42811
	premature death	J:42811, J:57671
	prolonged QT interval	J:57671
Slc18a2tm1Uhl/Slc18a2tm1Uhl involves: 129S7/SvEvBrd * C57BL/6J	neonatal lethality, incomplete penetrance	J:42811
	postnatal lethality, complete penetrance	J:42811
Slc18a2tm2Kmo/Slc18a2tm2Kmo involves: 129P2/OlaHsd * C57BL/6	abnormal circadian behavior	J:150414
	abnormal emotion/affect behavior	J:150414
	abnormal motor capabilities/coordination/movement	J:150414
	abnormal nervous system physiology	J:150414
	abnormal noradrenaline level	J:70606, J:150414
	abnormal response to new environment	J:70606
	abnormal response to novel odor	J:150414
	abnormal response to novelty	J:150414
	abnormal sleep pattern	J:150414
	alpha-synuclein inclusion body	J:123245
	decreased body weight	J:70606
	decreased coping response	J:150414
	decreased dopamine level	J:70606, J:123245, J:150414
	decreased dopaminergic neuron number	J:123245
	decreased locomotor activity	J:123245, J:150414
	decreased serotonin level	J:70606, J:150414
	impaired coordination	J:70606
	impaired gastric peristalsis	J:150414
	impaired olfaction	J:150414
	increased anxiety-related response	J:150414
	increased defecation amount	J:150414
	increased susceptibility to dopaminergic neuron neurotoxicity	J:70606
	normal muscle phenotype	J:150414
	neuron degeneration	J:123245
	stereotypic behavior	J:70606
	normal vision/eye phenotype	J:150414